BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial. (2016)
Attributed to:
Paediatric and adolescent infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3310/hta20490
PubMed Identifier: 27377073
Publication URI: http://europepmc.org/abstract/MED/27377073
Type: Journal Article/Review
Volume: 20
Parent Publication: Health technology assessment (Winchester, England)
Issue: 49
ISSN: 1366-5278